This grant, part of the NIH HEAL Initiative, is for accelerating scientific solutions to the national opioid crisis. The National Institute on Drug Abuse (NIDA), in collaboration with other NIH entities, seeks applications to develop and test interventions designed to prevent opioid misuse, opioid use disorder, and related co-occurring conditions, such as mental health issues or other substance use. The core focus is on intervening on social determinants of health (SDOH) to build an evidence base for effective, scalable interventions targeting social context factors. Applications must aim to reduce health inequities in U.S. populations impacted by the opioid crisis, examining the mechanisms by which theory-driven interventions achieve their preventive effects and promoting sustainable solutions.
Opportunity ID: 342264
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DA-23-051 |
| Funding Opportunity Title: | HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 – Clinical Trials Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.213 — Research and Training in Complementary and Integrative Health |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 13, 2022 |
| Last Updated Date: | Jul 13, 2022 |
| Original Closing Date for Applications: | Feb 02, 2023 |
| Current Closing Date for Applications: | Feb 02, 2023 |
| Archive Date: | Mar 10, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses State governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts City or township governments Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized) Special district governments Private institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | In April 2018, the National Institutes of Health (NIH) launched the Helping to End Addiction Long-term Initiative or HEAL Initiative, an aggressive, trans-agency effort to speed scientific solutions to stem the national opioid public health crisis. Through this initiative, the National Institute on Drug Abuse, in partnership with other NIH Institutes, Centers, and Offices, requests applications for studies designed to develop and test interventions to prevent opioid misuse, opioid use disorder, and co-occurring conditionsby intervening on social determinants of health (SDOH). This initiative aims to build an evidence base for interventions that target malleable factors and conditions affecting the social context. Applications must seek to reduce health inequities in a U.S. population or population subgroup affected by the opioid crisis by studyingthe effects of a theory driven intervention on the prevention of opioid misuse/opioid use disorder and co-occurring conditions. Such conditions could include mental health conditions and/or suicide, and may alsoinclude other substance use and substance use-related outcomes. The research project must examinethe mechanisms by which the interventions exert their effects. Investigators should study interventions that are sustainable and easily taken to scale if effective. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-051.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 342264 Full Announcement-RFA-DA-23-051 -> RFA-DA-23-051-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00275912 | Jan 02, 2023 | Jan 24, 2023 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00277857 | Jan 02, 2023 | Feb 02, 2023 | View |
Package 1
Mandatory forms
342264 RR_SF424_5_0-5.0.pdf
342264 PHS398_CoverPageSupplement_5_0-5.0.pdf
342264 RR_OtherProjectInfo_1_4-1.4.pdf
342264 PerformanceSite_4_0-4.0.pdf
342264 RR_KeyPersonExpanded_4_0-4.0.pdf
342264 PHS398_ResearchPlan_4_0-4.0.pdf
342264 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
342264 RR_Budget_3_0-3.0.pdf
342264 RR_SubawardBudget30_3_0-3.0.pdf
342264 PHS398_ModularBudget_1_2-1.2.pdf
342264 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
342264 RR_SF424_5_0-5.0.pdf
342264 PHS398_CoverPageSupplement_5_0-5.0.pdf
342264 RR_OtherProjectInfo_1_4-1.4.pdf
342264 PerformanceSite_4_0-4.0.pdf
342264 RR_KeyPersonExpanded_4_0-4.0.pdf
342264 PHS398_ResearchPlan_5_0-5.0.pdf
342264 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
342264 RR_Budget_3_0-3.0.pdf
342264 RR_SubawardBudget30_3_0-3.0.pdf
342264 PHS398_ModularBudget_1_2-1.2.pdf
342264 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
